CV summary Title & full name: Dr. Ir. Wouter van Elmpt Profession: Researcher / Physicist Institute, city, country: Department of Radiation Oncology (MAASTRO), Maastricht University Medical Centre, Maastricht, The Netherlands Contact details: Dr. Tanslaan 12, 6229 ET, Maastricht, NL – [email protected] Qualifications / education: Master of Science in Applied Physics, PhD degree from the Maastricht University Main areas of professional interest/specialisation: Radiation oncology, imaging Professional experience/appointments: Senior scientist at MAASTRO clinic, visiting scientist at the Eindhoven University of Technology Research interests: Functional and molecular imaging, PET/CT imaging, adaptive radiotherapy and dose-painting Professional membership & associations: ESTRO, ESR Honours and awards: ESTRO 2009 Accuray Award; Dutch Cancer Society Fellowship Top most international scientific publications/books: Lung Cancer & PET/CT imaging: van Elmpt W, Das M, Hüllner M, Sharifi H, Zegers C, Reymen B, Lambin P, Wildberger J, Troost EGC, Veit-Haibach P, De Ruysscher D, “Characterization of tumour heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer”, Radiother Oncol. 2013 Oct;109(1):65-70 W. van Elmpt, D. De Ruysscher, A. van der Salm, A. Lakeman, J. van der Stoep, D. Emans, E. Damen, M. Ollers, J. Sonke, J. Belderbos, “The PET-boost randomised phase II doseescalation trial in non-small cell lung cancer,” Radiother Oncol 104(1):67-71 (2012). C Zegers, W van Elmpt, R Wierts, H Sharifi, B Reymen, MC Öllers, F Hoebers, EGC. Troost, R Wanders, A van Baardwijk, J Eriksson, B Windhorst, FM Mottaghy, D De Ruysscher, P Lambin, “Hypoxia imaging with [18F]HX4 PET in NSCLC patients: defining optimal imaging parameters”, Radiother Oncol. 2013 Oct;109(1):58-64. De Ruysscher D, Sharifi H, Defraene G, Kerns SL, Christiaens M, De Ruyck K, Peeters S, Vansteenkiste J, Jeraj R, Van Den Heuvel F, van Elmpt W. “Quantification of radiationinduced lung damage with CT scans: The possible benefit for radiogenomics.” Acta Oncol. 2013 Oct;52(7):1405-10 W. van Elmpt, M. Öllers, A. Dingemans, P. Lambin, and D. De Ruysscher, “Response Assessment Using 18F-FDG PET Early in the Course of Radiotherapy Correlates with Survival in Advanced-Stage Non-Small Cell Lung Cancer,” J Nucl Med, 53(10):1514-20 (2012). W. van Elmpt, J. Hamill, J. Jones, D. De Ruysscher, P. Lambin and M. Öllers, “Optimal Gating compared to 3D and 4D PET reconstruction for characterization of lung tumours,” Eur. J. Nucl. Med. Mol. Imag. 38(5):843-855, 2011. Non-rigid registration: G. Janssens, J. Orban de Xivry, S. Fekkes, A. Dekker, B. Macq, P. Lambin and W. van Elmpt: Evaluation of non-rigid registration models for inter-fraction dose accumulation in radiotherapy, Med Phys 36(9):4268-4276, J. Spijkerman, D. Fontanarosa, M. Das, W. van Elmpt, “Validation of nonrigid registration in pretreatment and follow-up PET/CT scans for quantification of tumor residue in lung cancer patients”, JACMP 15(4):24o-250, 2014. In-vivo dosimetry W. van Elmpt, L. McDermott, S. Nijsten, M. Wendling, P. Lambin and B. Mijnheer: A literature review of electronic portal imaging for radiotherapy dosimetry, Radiother Oncol 88(3):289-309, 2008. W. van Elmpt, S. Nijsten, S. Petit, B. Mijnheer, P. Lambin and A. Dekker: 3D in vivo dosimetry using megavoltage cone-beam CT and EPID dosimetry, Int J Radiat Oncol Biol Phys 73(5):1580-1587, 2009. W. van Elmpt, S. Nijsten, A. Dekker, B. Mijnheer and P. Lambin: The next step in patient specific QA: 3D dose verification for conformal and intensity-modulated RT based on EPID dosimetry and Monte Carlo dose calculations, Radiother Oncol 86(1):86-92, 2008. W. van Elmpt, S. Petit, D. De Ruysscher, P. Lambin and A. Dekker: 3D dose delivery verification using repeated cone-beam imaging and EPID dosimetry for stereotactic body radiotherapy of non-small cell lung cancer, Radioth Oncol: 94(2):188-194, 2010. Hobbies: road and mountain biking, table tennis